Purchase Order AG4M55P170120
- Not listed
- The U.S. government awarded a $7,500 firm fixed-price purchase order to 10X Genomics, Inc. for a 12-month Chromium Assurance Plan covering instrument serial number 10492, with performance from September 29, 2019 through September 28, 2020. The contract, issued on March 28, 2019, supports a civilian federal agency within the Southeast Area and will be performed at 10X Genomics' headquarters in Pleasanton, California. No set-aside designation was applied to this award. 10X Genomics is a...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development, a civilian federal agency, to 10X Genomics, Inc., a biotechnology company in Pleasanton, California. The $9,999.00 order is for the Chromium Next GEM product, which is used for advanced single-cell and spatial genomic analysis. 10X Genomics has been awarded multiple federal contracts and task orders from NIH institutes, often with small business set-aside designations, to provide...
- This is a firm fixed price purchase order awarded by the Northeast Area of a civilian federal agency to 10X Genomics, Inc. for $21,888.50. The award is for 10X Genomics Chromium consumables to support single cell sequencing. The contract has no set-aside designation and is intended to supply these genomics products and services to support the agency's biomedical research efforts, particularly by the National Institutes of Health and its various institutes and centers. 10X Genomics is a life...
- The U.S. government awarded a purchase order valued at $22,816.72 to 10X Genomics, Inc. on June 25, 2021, with an ultimate completion date of August 4, 2021. This firm fixed-price contract, which includes $100 in shipping charges, was funded by a civilian federal agency within the Northeast Area and references Quote No. SQ3114069V1 provided by John Cigoni on May 27, 2021. The work is to be performed in Orient, New York. No set-aside designation was used for this procurement. 10X Genomics,...
- 10X Genomics, Inc. was awarded a purchase order on September 22, 2018, valued at $12,500 for a 12-month Chromium Assurance Plan covering maintenance and support services for a Chromium Controller instrument (Serial Number 10492). The contract was awarded without set-aside designation under a firm fixed-price arrangement by a civilian federal agency within the Southeast Area. Performance of this service is based in Pleasanton, California, with an ultimate completion date of September 28, 2019....
- <p>The Office of Logistics and Acquisition Operations awarded a purchase order to 10X Genomics, Inc. for Chromium Chip B Single Cell Kit and Chromium Single Cell 3' GEM, Library & Gel, Bead Kit on August 15, 2019, with a ceiling value of $22,067.00. Work is performed in Pleasanton, California. The order carries firm fixed price terms with an ultimate completion date of September 14, 2019. No set-aside applies.</p>
- This firm fixed price purchase order was awarded to 10X Genomics, Inc. (doing business as 10X Genomics) by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, for the provision of Chromium Next GEM Reagent Bundles in the amount of $21,645.00. The award has an ultimate completion date of September 30, 2023 and did not utilize a set-aside designation. 10X Genomics is a life sciences technology company that...
- The Food and Drug Administration (FDA) awarded a $90,562 firm fixed-price purchase order to 10X Genomics, Inc. for a Chromium X instrument and accessory kit, with performance completion targeted for September 7, 2023. The award, issued on September 7, 2022, was made without a set-aside designation and specifies Laurel, Maryland as the place of performance. 10X Genomics is a leading biotechnology company headquartered in Pleasanton, California, specializing in advanced genomic analysis...
- This is a federal contract award to 10X Genomics, Inc., a biotechnology company in Pleasanton, California, for the procurement of laboratory supplies. The contract has a ceiling value of $34,810.59 and a performance period ending on September 11, 2026. The contract is a purchase order with a firm fixed-price pricing type, awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract does not have a set-aside designation. 10X Genomics is the prime...
- This is a federal contract award from the Department of Health and Human Services' National Institutes of Health (NIH) to 10X Genomics, Inc., a life sciences technology company, for the provision of a Chromium Kit and Custom Libraries. The contract is a firm fixed price purchase order with a potential value of $22,333.00. There is no set-aside designation mentioned. 10X Genomics has provided a range of genomic analysis platforms, reagents, instruments, and bioinformatics software to federal...
The U.S. government awarded a firm fixed-price purchase order valued at $9,808.00 to 10X Genomics, Inc. for one Chromium Genome Chip Kit V2 (48 reactions) on September 19, 2017. The contract, which was performed in Pleasanton, California, carried an ultimate completion date of October 18, 2017. No set-aside designation was applied to this procurement, and the funding was provided by a civilian federal agency within the Southeast Area. 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and reagents, supplied this consumable research product to support federal biomedical research initiatives. This award represents a routine procurement of specialized genomic analysis consumables that enable high-resolution molecular analysis capabilities for federal research programs. The company has established itself as a key supplier to the federal research community, particularly to National Institutes of Health agencies conducting research across infectious diseases, cancer, neurological disorders, and other disease areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 9/19/17 |